Treating the disease once symptoms begin to show up, they argue, might be too late to have any real impact on the disease The search for a treatment hasn’t been going well. There are only four approved drugs that treat the symptoms of the disease, and several hopeful treatments have failed key studies over the last few months.
Category: Neurology
BIDMC scientists survey the state of sleep science
… Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth …
The sleeping brain in Parkinson’s disease: A focus on REM sleep…
The sleeping brain in Parkinson’s disease: A focus on REM sleep behaviour disorder and related parasomnias for practicing neurologists. Sleep disorders are common non-motor symptoms of Parkinson’s disease and include parasomnias, encompassing not only REM sleep behaviour disorder , and non-REM parasomnias.
A Massachusetts medical mystery
… The article appeared in the CDC’s Morbidity and Mortality Weekly Report, a journal with wide circulation among public health officials. Many of the cases emerged after the Massachusetts Department of Public Health sent an alert to neurologists, …
Report of Severe Adverse Effects of MS Drug Alemtuzumab
The multiple sclerosis therapy alemtuzumab–marketed in the United States as Lemtrada –may trigger severe, unpredictable adverse effects, according to German researchers. Writing in Lancet Neurology , the scientists report on two patients in whom the infusion of alemtuzumab significantly worsened symptoms.
New Guideline on How to Map Brain Prior to Epilepsy Surgery
Before epilepsy surgery, doctors may consider using brain imaging to locate language and memory functions in the brain instead of the more invasive procedure that is commonly used, according to a guideline published by the American Academy of Neurology in the January 11, 2017, online issue of NeurologyA , the medical journal of the American Academy of Neurology. It is the first evidence-based guideline that systematically reviewed all evidence for such an evaluation.
Experimental treatment shows early promise for improving Parkinson’s symptoms
About fourteen years ago, Bill Crawford noticed a persistent twitching in one of his fingers that was interfering with his rehearsal time as the music pastor at Porter Memorial Church. He’d noticed a few other things too, like weakness.
She knew death was near, but this mom was determined to live for her boys
Jason and Jessica Crowder learned she was terminally ill shortly after the birth of youngest son Jace, center, in 2010. Jessica continued work as a neurologist at Keesler Air Force Base, while making memories with her husband and children, including twins Jett, left, and Jackson.
Bracket Welcomes Clinical Vice President Lewis Fredane, MD to Global Team
A board certified neurologist with more than 30 years of clinical research experience, Fredane brings a strategic combination of clinical and industry research expertise to his new role. As Clinical Vice President, Dr. Fredane will serve as the Therapeutic Area Leader for neurology and will oversee Bracket’s eCOA, Rater Training, and Quality Assurance work in this important therapeutic area.
Doctors Can Diagnose Early Alzheimer’s Disease Through Sniff Test
Tests that measure sense of smell will become important for neurologists. The scientists discovered that lack of smell happens in early Alzheimer.
‘Local’ learning health system can improve clinical quality while reducing costs
Providing high-quality patient care while reducing costs is a significant goal in the current health care reform environment. The Institute of Medicine has specifically called for the establishment of “learning health systems” to address this challenge.